Surgery Partners, Inc. Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2023-04-20: Measure Adjusted EBITDA.
- 2024-04-25: Measure Adjusted EBITDA.
- 2025-04-24: Measure Adjusted EBITDA.
- 2025-04-24: Measure Net Revenue.
| Proxy filed | Measure |
|---|---|
| 2023-04-20 | Adjusted EBITDA |
| 2024-04-25 | Adjusted EBITDA |
| 2025-04-24 | Adjusted EBITDA |
| 2025-04-24 | Net Revenue |
| 2025-04-24 | Free Cash Flow |
| 2026-04-23 | Adjusted EBITDA |
| 2026-04-23 | Net Revenue |
| 2026-04-23 | Cash Flow |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |